Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 209286.20% institutional investors, 31.48% insiders. Cerity partners is the largest institutional shareholder, holding 150.25% of AKTX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akari Therapeutics	209286.20%	31.48%	-209217.68%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Cerity partners	23.64K	150.25%	$23.88K
Independent advisor alliance	10.89K	69.19%	$11.00K
Sabby management	179.78K	32.93%	$210.33K
Palo alto investors lp	146.02K	26.75%	$170.83K
Cresset asset management	18.41K	3.37%	$21.54K
Accent capital management	10.00K	1.83%	$11.70K
Newedge advisors	6.80K	1.25%	$7.96K
Eversource wealth advisors	44.00	0.28%	$44.00
Truvestments capital	50.00	0.01%	$59.00
Sbi securities	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sabby management	179.78K	0.38%	$210.33K
Palo alto investors lp	146.02K	0.04%	$170.83K
Accent capital management	10.00K	0.01%	$11.70K
Independent advisor alliance	10.89K	0.00%	$11.00K
Cresset asset management	18.41K	0.00%	$21.54K
Omnia family wealth	-	-	-
Cwa asset management group	-	-	-
Cornerstone planning group	-	-	-
Ubs group	-	-	-
Newedge advisors	6.80K	-	$7.96K

Top Buyers

Holder	Shares	% Assets	Change
Sabby management	179.78K	0.38%	179.78K
Independent advisor alliance	10.89K	0.00%	10.89K
Newedge advisors	6.80K	-	6.80K
Ifp advisors	181.00	-	181.00
Truvestments capital	50.00	-	-

Top Sellers

Holder	Shares	% Assets	Change
Warberg asset management	-	-	-308.34K
Hightower advisors	-	-	-79.24K
Cwa asset management group	-	-	-55.00K
Ubs group	-	-	-32.85K
Omnia family wealth	-	-	-28.44K

New Positions

Holder	Shares	% Assets	Change	Value
Sabby management	179.78K	0.38%	179.78K	$210.33K
Independent advisor alliance	10.89K	0.00%	10.89K	$11.00K
Newedge advisors	6.80K	-	6.80K	$7.96K
Ifp advisors	181.00	-	181.00	$932.00

Sold Out

Holder	Change
Cornerstone planning group	-5.00
Sbi securities	-200.00
Omnia family wealth	-28.44K
Ubs group	-32.85K
Cwa asset management group	-55.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	14	-12.50%	683,594	-41.58%	209,286	0.00%	8	60.00%	2	-33.33%
Sep 30, 2025	16	14.29%	1,170,067	112.45%	7,435	73.05%	6	20.00%	3	50.00%
Jun 30, 2025	15	50.00%	550,740	80.99%	100	32469.88%	5	-	3	200.00%
Mar 31, 2025	10	-28.57%	304,298	-5.73%	-	30.53%	-	-100.00%	1	-
Dec 31, 2024	14	40.00%	322,783	78.02%	1	244.43%	6	50.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	1.51K	0.01%	-
RiverNorth Marketplace Lending Corp	1.10K	0.00%	-
RiverNorth Opportunities	509.00	0.00%	-
LUX IM Global Medtech HX	64.00	0.00%	-10.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 16, 2025	Neal James R	-	Buy	$960.27
Dec 16, 2025	Neal James R	-	Buy	-
Dec 16, 2025	Neal James R	-	Buy	$1.20K
Dec 16, 2025	Neal James R	-	Buy	-
Dec 16, 2025	Prudo-Chlebosz Raymond	-	Buy	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	3	-
2025 Q2	4	-
2025 Q1	-	-
2024 Q4	-	-

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 209286.20%, followed by 31.48% insiders and -209217.68% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 382.13%, which Akari Therapeutics exceeds.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Cerity partners (23.64K shares, 150.25%), Independent advisor alliance (10.89K shares, 69.19%), and Sabby management (179.78K shares, 32.93%). Together, they hold 252.37% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Akari Therapeutics shares, with 0.01% of its total shares outstanding invested in 1.51K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools